Industries > Pharma > Global Transplant Market Forecast 2019-2029

Global Transplant Market Forecast 2019-2029

Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users

PUBLISHED: 18 December 2018
PAGES: 184
PRODUCT CODE: PHA0346

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The global transplant market will reach $29bn in 2019 and is estimated to grow at a CAGR of 9.9% from 2018- 2029. Visiongain estimated that Germany will hold 7.3% of the global transplant market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 184-page report you will receive 82 tables and 55 figures– all unavailable elsewhere.

The 184-page report provides clear detailed insight into the transplant market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Transplant Market from 2019-2029

• Forecast of the Global Transplant market by Product:
• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions

• Forecast of the Global Transplant market by Application:
• Tissue Transplant: Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues
• Organ Transplant: Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant

• Forecast of the Global Transplant market by End-user:
• Hospitals
• Transplant Centers
• Others

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: US, Canada
• EU: Germany, France, United Kingdom, Italy, Spain and rest of EU
• Asia-Pacific: Japan, China, India and rest of Asia-Pacific
• RoW: Brazil, Mexico, Russia, South Africa and rest of ROW

• Our study discusses the selected leading companies that are the major players in the transplant market:
• AbbVie, Inc.
• Arthrex, Inc.
• Medtronic
• Novartis AG
• Stryker
• Teva Pharmaceuticals
• Veloxis Pharmaceuticals
• Zimmer Biomet

• This study discusses the competitive landscape, including factors that drive and restrain the transplant market

• This report also provides the number organ transplant procedures from 2012-2017 in selected countries:
• The US
• Canada
• Germany
• UK
• France
• Italy
• Spain
• Japan
• China
• Brazil
• Mexico
• South Africa
• Russia

Visiongain’s study is intended for anyone requiring commercial analyses for the transplant market. You find data, trends and predictions.

Buy our report today Global Transplant Market Analysis : Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Transplant Market Forecast 2019-2029

    Download sample pages

    Complete the form below to download your free sample pages for Global Transplant Market Forecast 2019-2029

      Latest Pharma news

      Visiongain Publishes Antibiotics Market Report 2023-2033

      The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.

      31 January 2023

      READ

      Visiongain Publishes Clinical Trial Supplies Market Report 2023-2033

      The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.

      31 January 2023

      READ

      Visiongain Publishes Meningococcal Vaccines Market Report 2023-2033

      The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.

      31 January 2023

      READ

      Visiongain Publishes Human Microbiome Market Report 2023-2033

      The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.

      30 January 2023

      READ